Status
ACTIVE
Global HQ
United Kingdom
Countries of investment
- United Kingdom
- USA
Investment stages
- Seed
Industries
- Biotechnology
- Health Tech
- AI
About
Epidarex Capital is a transatlantic venture capital firm that focuses on investing in early-stage, high-growth life science and health technology companies in under-ventured markets, particularly within the UK and emerging hubs.
Epidarex Capital is a transatlantic venture capital firm that focuses on investing in early-stage, high-growth life science and health technology companies in under-ventured markets, particularly within the UK and emerging hubs.
Investment Thesis
Epidarex invests in early stage, highgrowth life science companies in emerging and underventured research hubs within the US and United Kingdom. They focus on disruptive platform technologies that address large and unmet medical needs, offering a sustainable competitive advantage.
Manager's Experience
Bringing a wealth of expertise in private equity, the fund manager has successfully executed numerous investments in the biotech and life sciences sectors, primarily across North America and Europe. With a focus on operator-first strategies, they’ve built a portfolio characterized by innovative companies, completing over 30 deals that span early to growth-stage investments. Notable exits include several high-profile IPOs and strategic acquisitions, showcasing a data-driven approach that enhances value creation. Their strategic style emphasizes thematic investing, aligning capital with emerging trends in healthcare innovation.
Team
Sinclair Dunlop
Mary Canning
Kyp Sirinakis
Isao Kikuchi
A. Sinclair Dunlop
Shaun Millican